LL-37-derived short antimicrobial peptide KR-12-a5 and its d-amino acid substituted analogs with cell selectivity, anti-biofilm activity, synergistic effect with conventional antibiotics, and anti-inflammatory activity

European Journal of Medicinal Chemistry
Eun Young KimSong Yub Shin

Abstract

KR-12-a5 is a 12-meric α-helical antimicrobial peptide (AMP) with dual antimicrobial and anti-inflammatory activities designed from human cathelicidin LL-37. We designed and synthesized a series of d-amino acid-substituted analogs of KR-12-a5 with the aim of developing novel α-helical AMPs that possess higher cell selectivity than KR-12-a5, while maintaining the anti-inflammatory activity. d-amino acid incorporation into KR-12-a5 induced a significant improvement in the cell selectivity by 2.6- to 13.6-fold as compared to KR-12-a5, while maintaining the anti-inflammatory activity. Among the three analogs, KR-12-a5 (6-(D)L) with d-amino acid in the polar-nonpolar interface (Leu(6)) showed the highest cell selectivity (therapeutic index: 61.2). Similar to LL-37, KR-12-a5 and its analogs significantly inhibited the expression and secretion of NO, TNF-α, IL-6 and MCP-1 from LPS-stimulated RAW264.7 cells. KR-12-a5 and its analogs showed a more potent antimicrobial activity against antibiotic-resistant bacteria, including clinically isolated MRSA, MDRPA, and VREF than LL-37 and melittin. Furthermore, compared to LL-37, KR-12-a5 and its analogs showed greater synergistic effects with conventional antibiotics, such as chloramphenicol, ...Continue Reading

Citations

Feb 13, 2018·Chembiochem : a European Journal of Chemical Biology·Sunithi GunasekeraUlf Göransson
Oct 13, 2017·Biofouling·Karina Sampaio CaiaffaCristiane Duque
Aug 10, 2019·Critical Reviews in Clinical Laboratory Sciences·Adriana Barreto-SantamaríaHernando Curtidor
Jul 18, 2019·Expert Opinion on Drug Discovery·Davor Juretić, Juraj Simunić
Mar 4, 2020·Current Topics in Medicinal Chemistry·Jiarui LiEster Boix
Oct 24, 2019·Scientific Reports·Pethaiah GunasekaranJeong Kyu Bang
Jun 13, 2020·Frontiers in Immunology·Darren Shu Jeng TingImran Mohammed
Jul 1, 2018·Biochimica Et Biophysica Acta. Biomembranes·Ganesan RajasekaranSong Yub Shin
Jun 3, 2021·Antibiotics·Kylen E Ridyard, Joerg Overhage
Oct 16, 2021·Journal of Agricultural and Food Chemistry·Shuhui ZhangAimin Ma
Nov 26, 2021·Frontiers in Microbiology·Luís MollAnna Bonaterra

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.